[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX9302711A - BASE PREPARATION. - Google Patents

BASE PREPARATION.

Info

Publication number
MX9302711A
MX9302711A MX9302711A MX9302711A MX9302711A MX 9302711 A MX9302711 A MX 9302711A MX 9302711 A MX9302711 A MX 9302711A MX 9302711 A MX9302711 A MX 9302711A MX 9302711 A MX9302711 A MX 9302711A
Authority
MX
Mexico
Prior art keywords
dibenz
tetrahydro
trans
chloro
methyl
Prior art date
Application number
MX9302711A
Other languages
Spanish (es)
Inventor
Petrus Johannes Maria Oetelaar
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of MX9302711A publication Critical patent/MX9302711A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe la sal de hemipatoato y pamoato de trans-5-cloro-2-metil-2, 3, 3, 3a, 12b-tetrahidro-1h-dibenz(2, 3; 6, 7)oxepino-(4, 5-c)pirrol, compuestos muy insolubles que tienen excelentes propiedades para utilizarse como preparaciones base. También se describen preparaciones farmacéuticas que incluyen a las sales de pamoato de trans-5-cloro-2-metil-2, 3, 3a, 12b-tetrahidro-1H-dibenz(2, 3; 6,/)oxepino-(4, 5-c)pirrol, especialmente en forma cristalina. Estas preparaciones liberan cantidades terapéuticamente útiles de trans-5-cloro-2-metil-2, 3, 3a, 12b-tetrahidro-1H-dibenz(2, 3; 6, 7) oxepino-(4, 5-c)pirrol durante 2 a 6 semanas después de la administración.The trans-5-chloro-2-methyl-2, 3, 3, 3a, 12b-tetrahydro-1h-dibenz (2, 3; 6, 7) oxepino- (4, 5-) salt is described. c) pyrrole, very insoluble compounds that have excellent properties to be used as base preparations. Pharmaceutical preparations including the trans-5-chloro-2-methyl-2, 3, 3a, 12b-tetrahydro-1H-dibenz (2, 3; 6, /) oxepine- (4, 5-c) pyrrole, especially in crystalline form. These preparations release therapeutically useful amounts of trans-5-chloro-2-methyl-2,3,3a, 12b-tetrahydro-1H-dibenz (2, 3; 6, 7) oxepine- (4, 5-c) pyrrole during 2 to 6 weeks after administration.

MX9302711A 1992-05-08 1993-05-07 BASE PREPARATION. MX9302711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92201319 1992-05-08

Publications (1)

Publication Number Publication Date
MX9302711A true MX9302711A (en) 1994-05-31

Family

ID=8210598

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302711A MX9302711A (en) 1992-05-08 1993-05-07 BASE PREPARATION.

Country Status (8)

Country Link
JP (1) JPH0656840A (en)
KR (1) KR930023338A (en)
AU (1) AU3846293A (en)
CA (1) CA2095499A1 (en)
FI (1) FI932088A (en)
MX (1) MX9302711A (en)
NO (1) NO931671L (en)
ZA (1) ZA933134B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000050I2 (en) * 1994-03-02 2011-07-21 Organon Nv Sublingual or buccal medicine.
AU759751B2 (en) * 1998-09-30 2003-05-01 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
DE10041479A1 (en) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh New pharmaceutical composition for the administration of N-0923
GB0216416D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
BRPI1011453A2 (en) * 2009-06-24 2016-03-15 Msd Oss Bv formulation, dosage form of a drug, and asenapine hemipamoate salt
JP2021014404A (en) * 2017-10-13 2021-02-12 アステラス製薬株式会社 Triazolopyrazine derivative salt and crystal

Also Published As

Publication number Publication date
NO931671L (en) 1993-11-09
FI932088A (en) 1993-11-09
NO931671D0 (en) 1993-05-07
FI932088A0 (en) 1993-05-07
ZA933134B (en) 1993-11-30
JPH0656840A (en) 1994-03-01
KR930023338A (en) 1993-12-18
AU3846293A (en) 1993-11-11
CA2095499A1 (en) 1993-11-09

Similar Documents

Publication Publication Date Title
ES2074124T3 (en) COMPOSITION IN THE FORM OF A FOAM CONTAINING 5-AMINOSALICYLIC ACID FOR INTRA-RECTAL ADMINISTRATION.
ES2032009T3 (en) PROCEDURE TO PREPARE INTERFERON STABLE COMPLEXES.
ES2069582T3 (en) THERAPEUTIC NUCLEOSIDES.
ES2061094T3 (en) A PROCEDURE FOR OBTAINING A FORMULATION TO DECREASE THE IMPERIOUS DESIRE OF ALCOHOL (CRAVING) IN THE TREATMENT OF CHRONIC ALCOHOLISM.
ES2084579T3 (en) USE OF BUSPIRONE IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALCOHOL ABUSE.
DK0605484T3 (en) Peptides with growth hormone releasing activity
AR218037A1 (en) PROCEDURE TO PREPARE A THERAPEUTIC SYSTEM IN THE FORM OF A SKIN PATCH FOR THE ADMINISTRATION OF THE CLONIDINE DRUG
DE68909772D1 (en) Diclofenac sodium drug preparation with extended release of active ingredient.
MX9201672A (en) COMPOUND OF PYRAZINE PIRIDINE AND PROCEDURE FOR THE PREPARATION OF THE SAME.
DK0598770T3 (en) Pyrazine derivatives and their preparation and use
SE9002500D0 (en) PHARMACEUTICAL, NAC CONTAINING COMPOSITION FOR ORAL ADMINISTRATION
ES2066062T3 (en) PREPARATION OF SUSTAINED RELEASE FOR ADMINISTRATION TO THE BRAIN.
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
GB1321509A (en) Azepine derivatives
SE503436C2 (en) Pyroglutamidderivat
MX9302711A (en) BASE PREPARATION.
ES2037095T3 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION.
FR2351942A1 (en) ACETYL-3-DIMETHYL-2,2-CYCLOPROPANECARBOXYLIC ACID DERIVATIVES FOR USE IN THE PREPARATION OF INSECTICIDES
GB2000025A (en) Nitroimidazole formulations
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
NO810480L (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES
SE8004383L (en) PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION AND PROCEDURE FOR ITS PREPARATION
SE8204792D0 (en) N-METHYL-D-GLUCAMINE SALT OF 3,4-DIHYDRO-5-METHYL-6- (2-METHYL-PROPYL) -4-OXOTIENO (2,3-D) PYRIMIDIN-2-CARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING THIS SALT
ES2043736T3 (en) 3,5-DIHYDROXY-HEPTANOIC ACIDS REPLACED WITH (1H-PIRROL-3-ILO) IN POSITION 7, ITS CORRESPONDING DELTA-LACTONES AND SALTS, PROCEDURES FOR THEIR PREPARATION, THEIR USE AS MEDICINES, PHARMACEUTICAL PREPARATIONS AND PRODUCTS.
FI880027A (en) ANTIBACTERIAL LYOPHILISED PREPARATIONS.